{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "72426-818",
      "generic_name": "Bempedoic Acid and Ezetimibe",
      "labeler_name": "Esperion Therapeutics, Inc.",
      "brand_name": "Nexlizet",
      "active_ingredients": [
        {
          "name": "BEMPEDOIC ACID",
          "strength": "180 mg/1"
        },
        {
          "name": "EZETIMIBE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "72426-818-03",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03)",
          "marketing_start_date": "20200309",
          "sample": false
        },
        {
          "package_ndc": "72426-818-99",
          "description": "7 TABLET, FILM COATED in 1 BLISTER PACK (72426-818-99)",
          "marketing_start_date": "20200309",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Esperion Therapeutics, Inc."
        ],
        "rxcui": [
          "2283230",
          "2283236"
        ],
        "spl_set_id": [
          "3fa2108c-0300-47b8-9d34-f762af7c93c6"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193913",
          "N0000193914",
          "N0000008553",
          "N0000175911"
        ],
        "pharm_class_epc": [
          "Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]",
          "Dietary Cholesterol Absorption Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Cholesterol Absorption [PE]"
        ],
        "unii": [
          "1EJ6Z6Q368",
          "EOR26LQQ24"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "29da37de-60f3-4dcc-8ccd-1b96631778bd",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200309",
      "product_id": "72426-818_29da37de-60f3-4dcc-8ccd-1b96631778bd",
      "application_number": "NDA211617",
      "brand_name_base": "Nexlizet",
      "pharm_class": [
        "Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]",
        "Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]",
        "Decreased Cholesterol Absorption [PE]",
        "Dietary Cholesterol Absorption Inhibitor [EPC]"
      ]
    }
  ]
}